Australia's Oncosil Medical rises on first cancer treatments in Greece

Oncosil Medical

08/12/2023 03:17

** Shares of Oncosil Medical  OSL.AX  rise as much as 18.8%
to A$0.0095, their best day since Nov. 14 - if current gains
hold 
    ** Stock hits highest level since Dec. 1 
    ** Cancer-focused medical device maker says Oncosil device
has commenced its initial commercial treatments for pancreatic
cancer treatment in Greece with two patients on Dec. 7 
    ** Says Greece is the third European country after Italy and
Spain to use Oncosil commercially 
    ** Stock on track for best week since Nov. 10 adding 5.6% in
value so far 
    ** About 1.4 mln shares change hands, compared with the
30-day average volume of 740,119 
    ** Stock has fallen 78.1his year, as of last close

 (Reporting by Sneha Kumar in Bengaluru)
 ((Sneha.Kumar@thomsonreuters.com;))